onclive· 2mo ago
save<![CDATA[FDA Accepts sNDA for Taletrectinib in ROS1+ NSCLC]]>
May 6, 2026read original ↗
<![CDATA[An sNDA with updated data for taletrectinib was accepted by the FDA for TKI-naive and pretreated advanced ROS1+ NSCLC]]>
Full text isn't available here yet — read it at onclive.
read full article on onclive ↗🔗 mentioned in this article
no entities indexed yet
comments(0)
5-min edit window · permanent after that